NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer

NCT02689921 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Exemestane
DRUG: Letrozole
DRUG: Anastrozole
DRUG: Leuprolide Acetate
DRUG: Pertuzumab
DRUG: Trastuzumab

Sponsor

Midwestern Regional Medical Center